PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Smolen, Josef S.
TI  - PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
DP  - 2011  01
TA  - MD Conference Express
PG  - 18--19
VI  - 11
IP  - 13
4099  - http://mdc.sagepub.com/content/11/13/18.short
4100  - http://mdc.sagepub.com/content/11/13/18.full
AB  - Data from the Randomized, Double-Blind Study Comparing the Safety & Efficacy of Once-Weekly Etanercept 50 mg, Etanercept 25 mg, & Placebo in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis [PRESERVE; NCT00565409] show that patients with moderately active rheumatoid arthritis (RA) achieve and maintain low disease activity and remission with anti-tumor necrosis factor therapy more successfully than those with high RA activity [Keystone E et al. J Rheumatol 2009].